Lymph Node Cancer Survival Rates: Hodgkin vs. Non-Hodgkin Lymphoma
The overall 5-year survival rate for all lymph node cancers (lymphomas) is approximately 70%, but prognosis varies significantly by type and stage.
Hodgkin Lymphoma
Hodgkin lymphoma has one of the highest cure rates among cancers.
- All stages combined: ~85% 5-year survival
- Early stage (I or II): ~95% 5-year survival
- Advanced stage (III or IV): ~80% 5-year survival
Non-Hodgkin Lymphoma (NHL)
NHL encompasses many subtypes with widely varying outcomes.
- Indolent (slow-growing) lymphomas (e.g., follicular, small lymphocytic): 70-80% 5-year survival; often managed as chronic disease.
- Aggressive (fast-growing) lymphomas (e.g., diffuse large B-cell, Burkitt): 50-60% 5-year survival; potentially curable with intensive chemotherapy.
Improving Trends
Survival rates have risen steadily due to advances in chemotherapy, immunotherapy (e.g., CAR-T cells), targeted therapy (e.g., BTK inhibitors), and radiation techniques. Early diagnosis and subtype-specific treatment are key.
Lymphoma - Related Articles
- Lymphatic Return Mechanisms: How Lymph Reaches the Bloodstream
- Major Lymph Node Clusters: Cervical, Axillary, and Inguinal
- Lymphoma Symptoms: Recognizing Common and Less Common Signs
- Lymph Node Cells: Key Players in Immune Defense - Macrophages & More
- Lymphocyte Organelles: Essential Components of Immune Cells
- Lymphopenia: Causes, Consequences, and Clinical Approach
- Understanding Diffuse Large B-Cell Lymphoma: Primary vs. Relapsed